Microstructure alterations in the hypothalamus in cranially radiated childhood leukaemia survivors but not in craniopharyngioma patients unaffected by hypothalamic damage

Clinical Endocrinology
Cecilia FollinEva Marie Erfurth

Abstract

Metabolic complications are frequent in childhood leukaemia (ALL) survivors treated with cranial radiotherapy (CRT). These complications are potentially mediated by damage to the hypothalamus (HT), as childhood onset (CO) craniopharyngioma (CP) survivors without HT involvement are spared overt obesity. Diffusion tensor imaging (DTI) shows brain tissue microstructure alterations, by fractional anisotrophy (FA), mean diffusivity (MD), axial diffusivity (AD) and radial diffusivity (RD). We used DTI to determine the integrity of the microstructure of the HT in ALL survivors. Case-control study. Three groups were included: (i) 27 CRT treated ALL survivors on hormone supplementation, (ii) 17 CO-CP survivors on hormone supplementation but without HT involvement and (iii) 27 matched controls. DTI parameters of the HT were measured and body composition. Microstructural alterations in the HT were more severe in ALL survivors with a BMI ≥25 than with BMI <25. Compared to controls, ALL survivors had reduced FA (P=.04), increased MD (P<.001), AD (P<.001) and RD (P<.001) in the right and left HT. In the right HT, ALL survivors with a BMI ≥25 showed elevated MD (P=.03) and AD (P=.02) compared to ALL survivors with BMI <25. In contrast, DTI pa...Continue Reading

References

Feb 1, 1987·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·F M BalisD G Poplack
Sep 1, 1981·Acta paediatrica Scandinavica·G GustafssonA Dohlwitz
Jan 1, 1994·Biophysical Journal·P J BasserD LeBihan
Dec 1, 1996·Radiology·C PierpaoliG Di Chiro
Feb 8, 2003·The Journal of Clinical Endocrinology and Metabolism·Robert H LustigThomas E Merchant
Dec 3, 2003·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·P A Tataranni, A DelParigi
May 6, 2004·The Journal of Clinical Endocrinology and Metabolism·Patrick MaisonUNKNOWN Metaanalysis of Blinded, Randomized, Placebo-Controlled Trials
Jul 9, 2004·The Journal of Clinical Endocrinology and Metabolism·Hermann L MüllerNiels Sörensen
Oct 9, 2004·The Journal of Clinical Endocrinology and Metabolism·Katarina LinkEva Marie Erfurth
Jun 30, 2007·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Andrew L AlexanderAaron S Field
Dec 8, 2007·Magnetic Resonance Imaging·Alpay AlkanGulnur Erdem
Mar 6, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Matthew D BuddeSheng-Kwei Song
Oct 14, 2009·Frontiers in Neuroendocrinology·Joshua P ThalerBrent E Wisse
Nov 20, 2009·IEEE Transactions on Medical Imaging·Stefan KleinJosien P W Pluim
Mar 5, 2010·IEEE Transactions on Medical Imaging·Dirk H J PootJan Sijbers
Apr 15, 2011·European Journal of Endocrinology·Hermann L MüllerUNKNOWN Study Committee of KRANIOPHARYNGEOM 2000
Oct 8, 2011·NeuroImage·Mark JenkinsonStephen M Smith
Aug 21, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ilse SchuitemaLeo M J de Sonneville
Nov 14, 2013·The Journal of Endocrinology·Marc SchneebergerMarc Claret
Jun 16, 2014·Nature Medicine·Rachel J PerryGerald I Shulman
Nov 26, 2014·The Journal of Clinical Endocrinology and Metabolism·Josep PuigJosé Manuel Fernández-Real

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.